Avandia Vision Problems Confirmed by New Study

While prior reports have linked the use of Avandia to vision problems, new research confirms that side effects of Avandia and Actos, another diabetes drug in the same class of medications, increase the risk of the potentially blinding condition, diabetic macular edema.

Avandia (rosiglitazone) and Actos (pioglitazone) are members of a class of medications known as glitazones, which are used to treat type 2 diabetes by helping the body utilize the available amounts of insulin in a more effective manner.

Over the past two years, substantial concerns have emerged about the safety of the drugs, especially Avandia, which has been linked to an increased risk of heart attacks, congestive heart failure, liver failure, bone fractures, vision loss and death.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Due to the mounting evidence of potentially life-threatening side effects, consumer advocacy groups have called for a recall of Avandia and many experts have questioned the rationale for continued use of the drug.

A new study published in the current issue of the American Journal of Ophthalmology provides confirmation in a very large sample of diabetics that glitazones increase the risk of vision problems. Users of the drugs were found to be 2.6 times more likely to develop diabetic macular edema, a condition in which swelling and fluid build-up in the retina, leading to progressive vision loss.

Researchers from the Southern California Permanente Medical Group analyzed a database of about 170,000 patients with diabetes and identified 996 that were diagnosed with diabetic macular edema. Even when the data was adjusted to account for other factors, diabetes patients taking Avandia and Actos were found to face a 60% higher risk of developing macular edema.

A number of Avanida vision loss lawsuits are among the thousands of cases which have been filed against GlaxoSmithKline PLC in federal and state courts throughout the United States. All federal Avandia lawsuits have been consolidated in U.S. District Court for the Eastern District of Pennsylvania, where the first trials are expected to begin in the second half of 2010.

1 Comments

  • curtisApril 17, 2010 at 2:04 am

    I had colon cancer surgery 19 sep 06 within 12 hours I suffered congestive heart failure with blood clots in each lung and my right leg. I had a history of taking Avandia and Actos for 2 years prior to surgery. I also had vision problems for approximately 2 months until by medicine was changed. Note: I am 72 years of age.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.